Groundbreaking Clinical Trial To Assess Use Of Newborn Stem Cells In The Treatment Of Pediatric Stroke

SAN BRUNO, Calif., July 13, 2015 /PRNewswire/ — Cord Blood Registry® (CBR®) announces the launch of an FDA-regulated clinical trial to investigate autologous stem cell therapy in children diagnosed as having had a prenatal or perinatal pediatric stroke.

[Read the full article here]

Comments are closed.